Valuation: Easton Pharmaceuticals Inc.

Market Cap 269K 235K 221K 201K 377K 25.81M 378K 2.65M 1.02M 13.12M 1.01M 988K 42.22M P/E 2019
-4.17x
P/E 2020 -4.29x
Enterprise Value 2.75M 2.4M 2.27M 2.06M 3.85M 264M 3.87M 27.14M 10.47M 134M 10.34M 10.11M 432M EV / Sales 2019
6.27x
EV / Sales 2020 -
Free-Float
97.34%
Yield 2019 *
-
Yield 2020 -
21-12-22 Parallel Industries Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2021 CI
19-09-26 Easton Pharmaceuticals Inc. cancelled the acquisition of Boutique Hotel and Real Estate Asset in the Heart of Toronto, Ontario, Canada. CI
19-06-13 Easton Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2019 CI
19-04-30 Easton Pharmaceuticals Inc. Moves its Corporate Head Office CI
19-04-25 Easton Pharmaceuticals Inc. acquired Supreme Sweets Inc. from Barbara and Mario Parravano. CI
19-03-27 Easton Pharmaceuticals Inc. Signs LOI with Licensed Producer of Cannabis to Expand its Operations and Participate in its Cannabis Edibles Division CI
19-03-10 Easton Pharmaceuticals Inc. Commences Cannabis Edibles Division CI
19-02-05 Easton Pharmaceuticals Inc. Announces Updates on its $2,600,000 Framing Contract to Construct 150 Homes as Well as Other Initiatives CI
19-01-23 Easton Pharmaceuticals Inc. Announces Sales Results for the Quarter Ended September 30, 2018 and December 31, 2018 CI
19-01-11 Easton Pharmaceuticals Inc. Provides Operational Update on CAD 2,600,000 Framing Contract CI
19-01-02 Easton Pharmaceuticals Announces Signing and Commencement of CAD 2,600,000 Framing Contract to Construct 150 Homes CI
18-11-28 Gunpowder Capital Corp. cancelled the acquisition of iBliss Inc. from Easton Pharmaceuticals Inc.. CI
18-09-26 Easton Pharmaceuticals Inc. signed a letter of intent to acquire Boutique Hotel and Real Estate Asset in the Heart of Toronto, Ontario, Canada. CI
Manager TitleAgeSince
Chief Executive Officer - 2015-06-29
Chief Operating Officer - 2018-06-19
Chief Tech/Sci/R&D Officer - 2014-12-31
Director TitleAgeSince
Director/Board Member - 2015-06-29
Director/Board Member - 2018-06-19
Change 5-day change 1-year change 3-year change Capi.($)
+30.43%+27.78% - - 134K
-0.31%+5.79%+48.93%+97.53% 70.88B
+0.39%+2.06%+40.91%+78.49% 62.49B
-3.21%-7.27%-17.73%+351.98% 26.21B
+0.50%+7.13%+29.43%+15.48% 26.34B
-2.64%-0.69%-0.26%-11.90% 24.13B
+0.71%+8.03%+27.22%-13.18% 20.72B
-1.26%-7.81%+169.33%+302.38% 15.36B
-0.22%+3.99%+44.28%+173.35% 14.46B
+0.73%+1.71%-7.18%+886.19% 14.25B
Average +2.51%+1.65%+37.22%+208.92% 30.54B
Weighted average by Cap. -0.47%+1.44%+36.51%+147.97%

Financials

2019 2020
Net sales 1.56M 1.36M 1.28M 1.16M 2.18M 149M 2.19M 15.34M 5.92M 75.89M 5.84M 5.71M 244M -
Net income -323K -282K -266K -242K -453K -31.01M -455K -3.19M -1.23M -15.77M -1.21M -1.19M -50.73M -189K -164K -155K -141K -264K -18.09M -265K -1.86M -718K -9.2M -708K -693K -29.6M
Net Debt 8.41M 7.33M 6.93M 6.29M 11.78M 807M 11.83M 82.96M 32.01M 410M 31.6M 30.9M 1.32B 2.48M 2.16M 2.04M 1.86M 3.48M 238M 3.49M 24.48M 9.45M 121M 9.33M 9.12M 390M
Logo Easton Pharmaceuticals Inc.
Parallel Industries Inc., formerly Easton Pharmaceuticals, Inc., is a development-stage company engaged in various pharmaceutical sectors and other industries. The Company has a transdermal delivery technology (Viorra Delivery Matrix or VDM), which is incorporated in a line of therapeutic over-the-counter (OTC) products. The Company owns topically-delivered drugs and therapeutic/cosmetic healthcare products focused on cancer and other health problems geared towards female sexual dysfunction, wound healing, pain, motion sickness and other conditions. The Company's products are in various stages of commercialization. The Company's products include Nauseasol, which is a motion sickness gel; Skin Renou HA, which is an anti-aging wrinkle cream; Kenestrin Gel, which is a pain relief gel; Viorra, which serves as an aid to the relief of female sexual arousal disorder (FSAD); XILIVE, which is an early-stage cancer drug, and FSAD) drug, which includes a water-based complex polymer matrix.
Employees
-
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!